RHRomain Hany

Romain Hany

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Romain Hany has a total of 8 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A Straightforward and Versatile Synthetic Route to Tunable Cyclic Lipopeptides for Fluorescent Echinocandin Analogues

    by Mylène Lang, Stéphanie Riché, Lucie Brendel, Clémentine Leger, Romain Hany, Halina Anton, Dominique Bonnet, Alina Marcela Sabou, Line Bourel

    Echinocandins (ECs) are semisynthetic lipocyclohexapeptides introduced in the 2000s to treat invasive fungal infections. They selectively and safely inhibit fungal β-(1,3)-D-glucan synthase, a key enzyme for fungal cell wall integrity, but their precise mechanism remains unclear. Their widespread use has led to emerging resistances, underscoring the need for molecular probes to investigate their action and resistance mechanisms. Due to their structural complexity, only few total syntheses and very limited fluorescent analogues have been reported. Here, we present a solid-phase peptide synthesis (SPPS) strategy to readily access to the EC pharmacophore and to novel fluorescent analogues. Using a safety-catch linker resin, cyclization and cleavage are efficiently combined, affording high-purity cyclic lipopeptides with simplifiedpurification step. Depending on the design, fluorescent tags were introduced either on-resin or in solution via bioconjugation. Several analogues retained antifungal activity against Candida albicans, and their interaction with fungal cells was visualized by confocal microscopy. This versatile methodology delivers some of the first fully synthetic fluorescent echinocandins, providing powerful tools to explore their mechanisms of action and fungal resistance.